Overview of Recombinant Protein Market: Forecast, Trend Analysis and Competition Tracking: Global Review 2017 to 2022

A freshly compiled business intelligent report, titled “Recombinant Proteins Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been publicized to the vast archive of Fact.MR online repository. This 170-page study delivers all the vital details and information required to know about recombinant protein market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=186

Clinical trial period for recombinant protein is shorter as compared to small molecule drugs. This further helps in enhancing the patient protection, providing pharmaceutical companies with longer exclusive sales time. These factors have fueled the development as well as demand for recombinant protein. Recombinant proteins are targeted at major diseases including endocrine diseases, cardiovascular diseases, cancer, and viral diseases. Moreover, the global market for recombinant proteins has larger extension space. Few approval drugs are available in the recombinant protein market, with no substitute products in therapeutic areas. However, owing to higher financial barriers, and technical barriers, recombinant proteins are subject to high costs. Replicating recombinant proteins is a more difficult task than that of small molecule chemicals. Fact.MR’s report projects the global market for recombinant protein to expand at an average CAGR during the forecast period (2017 to 2022). The market is estimated to account for nearly US$ 460 Mn revenues by 2022-end.

North America to Remain Dominant in the Market

North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.

Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Recombinant proteins will continue to find the largest application in basic research activities. Revenues from recombinant proteins for basic research are expected to account for around US$ 270 Mn by 2022-end. Drug discovery & development, and toxicity screening are estimated to emerge as the fastest growing applications of recombinant proteins. Sales of recombinant proteins for application in forensic testing are estimated to register the lowest CAGR through 2022.

Competition Tracking

Leading players in the global recombinant protein market include Abcam plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., BPS Bioscience Inc., PerkinElmer, Inc., Crown Bioscience, Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich, and Thermo Fisher Scientific, Inc.

Browse Full Report with TOC@ https://www.factmr.com/report/186/recombinant-protein-market

Table of Contents:

Global Recombinant Proteins Market – Executive Summary
Global Recombinant Proteins Market Overview
2.1. Introduction
2.1.1. Global Recombinant Proteins Market Taxonomy
2.1.2. Global Recombinant Proteins Market Definition
2.2. Global Recombinant Proteins Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Recombinant Proteins Market Y-o-Y Growth
2.3. Global Recombinant Proteins Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Recombinant Proteins Market Analysis and Forecast By Product Type
3.1. Global Recombinant Proteins Market Size and Forecast By Product Type, 2012-2022
3.1.1. Immune Checkpoint Regulators Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued………..

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=186

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.